bupropion is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Bupropion Hydrochloride.
| Product ID | 71335-0801_4f041df8-4394-4e15-826f-08277266253d |
| NDC | 71335-0801 |
| Product Type | Human Prescription Drug |
| Proprietary Name | bupropion |
| Generic Name | Bupropion Hydrochloride |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-11-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202304 |
| Labeler Name | Bryant Ranch Prepack |
| Substance Name | BUPROPION HYDROCHLORIDE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2022-02-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA202304 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-05-03 |
| Marketing End Date | 2019-08-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202304 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-05-03 |
| Marketing End Date | 2019-08-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202304 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-05-03 |
| Marketing End Date | 2019-08-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202304 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-05-03 |
| Marketing End Date | 2019-08-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202304 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-05-03 |
| Marketing End Date | 2019-08-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202304 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-05-03 |
| Marketing End Date | 2019-08-31 |
| Ingredient | Strength |
|---|---|
| BUPROPION HYDROCHLORIDE | 200 mg/1 |
| SPL SET ID: | 732690c9-eb8a-47a9-9cba-15d07df4e340 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68001-264 | bupropion | bupropion |
| 68382-353 | bupropion | bupropion |
| 68382-354 | bupropion | bupropion |
| 68788-7249 | bupropion | bupropion |
| 68788-9255 | bupropion | bupropion |
| 70518-1644 | bupropion | bupropion |
| 71335-0801 | bupropion | bupropion |
| 71335-0785 | bupropion | bupropion |
| 0615-8262 | bupropion | bupropion |
| 43547-288 | bupropion | bupropion |
| 43547-289 | bupropion | bupropion |
| 43547-290 | bupropion | bupropion |
| 50090-3854 | bupropion | bupropion |
| 50436-0289 | bupropion | bupropion |
| 55700-644 | bupropion | bupropion |
| 63187-521 | bupropion | bupropion |
| 65841-780 | bupropion | bupropion |
| 65841-836 | bupropion | bupropion |
| 70934-151 | bupropion | bupropion |
| 63629-8036 | bupropion | bupropion |
| 68788-7283 | bupropion | bupropion |
| 68071-5214 | bupropion | bupropion |
| 70518-2641 | bupropion | bupropion |
| 51655-357 | bupropion | bupropion |
| 71335-1622 | bupropion | bupropion |
| 0115-5445 | Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE |
| 0115-6811 | Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE |
| 0185-0410 | Bupropion Hydrochloride | Bupropion Hydrochloride |
| 0185-0415 | Bupropion Hydrochloride | Bupropion Hydrochloride |
| 0185-1111 | Bupropion Hydrochloride | Bupropion Hydrochloride |
| 0173-0135 | WELLBUTRIN | bupropion hydrochloride |
| 0173-0722 | WELLBUTRIN | bupropion hydrochloride |
| 0173-0947 | WELLBUTRIN | bupropion hydrochloride |
| 0173-0556 | ZYBAN | bupropion hydrochloride |